Both in Pharmaceuticals
PDS Biotechnology vs Serina Therapeutics
Over the past year PDSB returned −26.4% and SER returned −57.5%; their daily moves had a correlation of 0.02.
PDSB −26.4% SER −57.5%Growth of $1, one year, split-adjusted
| Metric | PDSB | SER |
|---|---|---|
| Price | $0.7429 | $2.08 |
| Market cap | $53.8M | $52.8M |
| Today | −3.00% | +3.48% |
| 1 month | +252.3% | −15.4% |
| 6 months | +38.5% | +15.6% |
| Year to date | −3.5% | +8.7% |
| 1 year | −27.2% | −58.1% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.2M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 276.2% | 79.2% |
| Short % of float | 12.2% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).